As of 2024-07-27, the Relative Valuation of Novavax Inc (NVAX) is (96.76) USD. This relative valuation is based on P/E multiples. With the latest stock price at 17.11 USD, the upside of Novavax Inc based on Relative Valuation is -665.5%.
The range of the Relative Valuation is (92.69) - (93.08) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 32.6x - 43.1x | 36.6x |
| Forward P/E multiples | 30.8x - 32.8x | 31.6x |
| Fair Price | (92.69) - (93.08) | (96.76) |
| Upside | -641.7% - -644.0% | -665.5% |
| Date | P/E |
| 2024-07-26 | -6.03 |
| 2024-07-25 | -5.87 |
| 2024-07-24 | -5.42 |
| 2024-07-23 | -5.77 |
| 2024-07-22 | -5.26 |
| 2024-07-19 | -4.88 |
| 2024-07-18 | -5.27 |
| 2024-07-17 | -5.58 |
| 2024-07-16 | -5.79 |
| 2024-07-15 | -5.32 |
| 2024-07-12 | -4.62 |
| 2024-07-11 | -4.56 |
| 2024-07-10 | -4.20 |
| 2024-07-09 | -4.17 |
| 2024-07-08 | -4.25 |
| 2024-07-05 | -4.19 |
| 2024-07-03 | -4.42 |
| 2024-07-02 | -4.57 |
| 2024-07-01 | -4.48 |
| 2024-06-28 | -4.46 |
| 2024-06-27 | -4.52 |
| 2024-06-26 | -4.62 |
| 2024-06-25 | -4.93 |
| 2024-06-24 | -4.94 |
| 2024-06-21 | -4.93 |
| 2024-06-20 | -4.95 |
| 2024-06-18 | -4.85 |
| 2024-06-17 | -4.95 |
| 2024-06-14 | -5.07 |
| 2024-06-13 | -5.30 |
| 2024-06-12 | -5.59 |
| 2024-06-11 | -5.89 |
| 2024-06-10 | -5.64 |
| 2024-06-07 | -6.40 |
| 2024-06-06 | -6.89 |
| 2024-06-05 | -7.38 |
| 2024-06-04 | -6.25 |
| 2024-06-03 | -6.42 |
| 2024-05-31 | -5.29 |
| 2024-05-30 | -5.37 |
| 2024-05-29 | -5.32 |
| 2024-05-28 | -5.46 |
| 2024-05-24 | -5.46 |
| 2024-05-23 | -5.34 |
| 2024-05-22 | -5.53 |
| 2024-05-21 | -5.25 |
| 2024-05-20 | -5.21 |
| 2024-05-17 | -4.58 |
| 2024-05-16 | -5.07 |
| 2024-05-15 | -4.54 |